PBPIA
FUSN
Pivotal bioVenture Partners Investment Advisor’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-563,385
| Closed | -$12M | – | 11 |
|
2024
Q1 | $12M | Sell |
563,385
-997,597
| -64% | -$21.3M | 7.72% | 5 |
|
2023
Q4 | $15M | Hold |
1,560,982
| – | – | 3.81% | 5 |
|
2023
Q3 | $4.06M | Hold |
1,560,982
| – | – | 1.62% | 7 |
|
2023
Q2 | $7.29M | Hold |
1,560,982
| – | – | 2.4% | 7 |
|
2023
Q1 | $5.88M | Sell |
1,560,982
-2
| -0% | -$8 | 2.42% | 7 |
|
2022
Q4 | $4.92M | Hold |
1,560,984
| – | – | 2.14% | 6 |
|
2022
Q3 | $4.7M | Buy |
1,560,984
+2
| +0% | +$6 | 1.72% | 9 |
|
2022
Q2 | $3.89M | Sell |
1,560,982
-37,395
| -2% | -$93.1K | 1.96% | 8 |
|
2022
Q1 | $12.4M | Hold |
1,598,377
| – | – | 5.88% | 4 |
|
2021
Q4 | $6.51M | Sell |
1,598,377
-2
| -0% | -$8 | 2.72% | 10 |
|
2021
Q3 | $12.7M | Buy |
1,598,379
+2
| +0% | +$16 | 4.47% | 9 |
|
2021
Q2 | $12.6M | Sell |
1,598,377
-2
| -0% | -$16 | 4.97% | 8 |
|
2021
Q1 | $17.1M | Hold |
1,598,379
| – | – | 5.5% | 7 |
|
2020
Q4 | $18.8M | Buy |
+1,598,379
| New | +$18.8M | 6.19% | 7 |
|